Stay updated on Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, signaling an access restriction rather than an update to the study details.SummaryDifference17%

- Check47 days agoChange DetectedRevision indicates the platform was updated from v3.6.5 to v3.6.6, a minor version bump. This update does not alter study data, eligibility criteria, or other core content on the page.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page shows a new revision label, updating from v3.6.4 to v3.6.5, indicating a new build/deployment. No visible content or functionality changes were made.SummaryDifference0.1%

- Check82 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a minor version bump with no visible changes to the study details.SummaryDifference0.1%

- Check103 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a minor backend/content-management update.SummaryDifference0.1%

Stay in the know with updates to Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.